Market News (Page 2) - TendieTensor

Market News Page 2 of 283 • 7,066 articles

Toll Brothers Announces Model Home Grand Opening at Woodinville Square in Woodinville, Washington

GlobeNewswire Inc. • Toll Brothers, Inc.

Toll Brothers Announces Model Home Grand Opening at Woodinville Square in Woodinville, Washington

01/12/2026 03:55 PM • Toll Brothers announced the grand opening of two designer-decorated model homes at Woodinville Square, a new luxury townhome community in Woodinville, Washington. The event takes place on January 17, 2026, featuring three-bedroom townhomes priced from the mid-$800,000s with 3.5 baths and open floor plans. The community offers convenient access to the Schoolhouse District, wine-tasting venues, dining, and the 42-mile Eastrail Trail system.

TOL - The company is expanding its luxury home portfolio with new model home openings and communities, demonstrating business growth and market presence. The announcement highlights strong product offerings, prime locations, and continued development across multiple markets, indicating positive business momentum.

#luxury homes #townhomes #grand opening #Woodinville #real estate development #model homes #Pacific Northwest

Skye Bioscience, Inc. (NASDAQ: SKYE) Securities Class Action: Johnson Fistel Reminds Investors of January 16 Deadline to Seek Lead Plaintiff Appointment

GlobeNewswire Inc. • Johnson Fistel, Pllp

Skye Bioscience, Inc. (NASDAQ: SKYE) Securities Class Action: Johnson Fistel Reminds Investors of January 16 Deadline to Seek Lead Plaintiff Appointment

01/12/2026 03:53 PM • Johnson Fistel announces a class action lawsuit against Skye Bioscience for investors who purchased securities between November 4, 2024 and October 3, 2025. The lawsuit alleges the company made materially false and misleading statements about its drug candidate nimacimab, overstating its effectiveness and commercial prospects. Investors must seek lead plaintiff appointment by January 16, 2026.

SKYE - The company is the subject of a securities class action lawsuit alleging material misrepresentations about its drug candidate's effectiveness and commercial prospects, resulting in substantial investor losses when the truth was disclosed on October 3, 2025.

#class action lawsuit #securities fraud #Skye Bioscience #nimacimab #lead plaintiff #investor losses #misleading statements

Peterson Wealth Buys $32 Million of JPMorgan Active Bond ETF, According to Recent SEC Filing

The Motley Fool • Eric Trie

Peterson Wealth Buys $32 Million of JPMorgan Active Bond ETF, According to Recent SEC Filing

01/12/2026 03:30 PM • Peterson Wealth Advisors increased its position in JPMorgan Active Bond ETF (JBND) by 596,642 shares worth approximately $32.37 million in Q4 2025, bringing its total stake to $47.49 million or 6.33% of reportable AUM. The purchase reflects the firm's preference for actively managed fixed income exposure to navigate uncertain rate environments and maintain steady income with lower volatility.

JBND - Significant institutional investment of $32 million by Peterson Wealth signals confidence in the ETF's active management approach. The purchase demonstrates investor preference for flexibility in bond allocation during uncertain rate environments, and the ETF's 4.44% dividend yield and 8.68% 1-year return support its appeal as a reliable income-generating core holding.

#SEC filing #bond ETF #active management #fixed income #institutional investment #portfolio allocation

Precision Neuroscience™ and Medtronic Partner to Integrate Layer 7 Brain–Computer Interface with Medtronic Neurosurgical Platform

GlobeNewswire Inc. • Na

Precision Neuroscience™ and Medtronic Partner to Integrate Layer 7 Brain–Computer Interface with Medtronic Neurosurgical Platform

01/12/2026 03:00 PM • Precision Neuroscience and Medtronic announced a strategic partnership to co-develop an integrated neurosurgical solution combining Precision's Layer 7 cortical interface with Medtronic's StealthStation surgical navigation system. The partnership aims to provide real-time functional and structural brain information in the operating room, advancing neurosurgical precision and decision-making.

NTAP - Aligned with security-focused innovations and quantum threat protection
MDT - Medtronic is expanding its neuroscience portfolio by integrating advanced brain-mapping technology into its existing trusted platforms. The partnership positions the company at the forefront of next-generation neurosurgical solutions and demonstrates commitment to innovation in neurological care.

#brain-computer interface #BCI technology #neurosurgery #surgical navigation #cortical interface #partnership #medical technology

Fermi Inc. (FRMI) Slapped With Securities Class Action Over IPO And Subsequent Disclosures -- Hagens Berman

GlobeNewswire Inc. • Hagens Berman

Fermi Inc. (FRMI) Slapped With Securities Class Action Over IPO And Subsequent Disclosures -- Hagens Berman

01/12/2026 02:57 PM • Fermi Inc. faces a securities class action lawsuit alleging its IPO materials were misleading regarding tenant demand for Project Matador. The company's anchor tenant terminated a $150 million funding agreement in December 2025, causing Fermi's stock to plunge 33% in a single day and 52% below its October IPO price of $21.

CEG - Gained 3.49% after securing a $1 billion Department of Energy loan to restart the Crane Clean Energy Center, expected to create 3,400 jobs
FRMI - Company faces securities fraud allegations over misleading IPO disclosures regarding tenant demand. Anchor tenant terminated $150M funding agreement, causing 33% single-day stock decline and 52% drop from IPO price, indicating severe loss of investor confidence and potential financial distress.

#securities class action #IPO #misleading disclosures #Project Matador #tenant termination #stock price decline #data center #AI infrastructure

Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

Ardent Health (ARDT) Hit With Securities Class Action Amid Receivables and Reserves Issues Driving 33% Plunge – Hagens Berman

01/12/2026 02:57 PM • Ardent Health (ARDT) faces a securities class action lawsuit following Q3 2025 disclosures revealing $90 million in adverse accounting adjustments related to accounts receivable collectability and liability reserves. The company's stock plunged 33% after revealing a $42.6 million revenue decrease and $47.2 million increase in professional liability reserves. Investors allege company leadership failed to disclose material weaknesses in internal controls, instead using a 180-day cliff reserve method rather than the detailed historical collection reviews previously claimed.

ARDT - Company disclosed significant accounting issues totaling ~$90 million in adverse adjustments, including $42.6 million revenue decrease and $47.2 million reserve increase. Stock fell 33% following disclosures. Securities class action alleges management failed to disclose material weaknesses in internal controls and used misleading accounting practices regarding revenue recognition and receivables collectability.

#securities class action #accounting adjustments #accounts receivable #revenue recognition #internal controls #reserves #stock plunge #investor fraud

Westwood One and Barbasol Celebrate 20 Years of Partnership Sponsoring the NFL on Westwood One

GlobeNewswire Inc. • Not Specified

Westwood One and Barbasol Celebrate 20 Years of Partnership Sponsoring the NFL on Westwood One

01/12/2026 02:56 PM • Cumulus Media's Westwood One and Barbasol marked the 20th anniversary of their NFL sponsorship partnership, one of sports media's longest-running brand collaborations. The partnership has spanned two decades of NFL coverage from Boomer Esiason to Kurt Warner, while also generating significant community impact through donations to the Boomer Esiason Foundation and Kurt Warner's Treasure House.

DASH - Advanced 2.20% following a Jefferies upgrade and a new partnership with Family Dollar for on-demand delivery
CMLS - The company is highlighted for maintaining a rare 20-year partnership demonstrating strong business relationships, brand trust, and successful long-term strategy in a volatile media landscape. The partnership's longevity and expansion into new creative integrations suggest operational stability and growth potential.

#Barbasol #Westwood One #NFL sponsorship #20-year partnership #Cumulus Media #brand loyalty #sports media

Why Tempus AI Stock Is Trading Higher On Monday?

Benzinga • Lekha Gupta

Why Tempus AI Stock Is Trading Higher On Monday?

01/12/2026 02:53 PM • Tempus AI (NASDAQ: TEM) stock rose on Monday following the release of preliminary fourth-quarter and full-year 2025 results showing $1.27 billion in revenue with 83% year-over-year growth. The company also announced two major strategic partnerships: a multi-year collaboration with NYU Langone Health to advance cancer care through molecular profiling, and a contract with Northwestern Medicine to broaden access to genomic testing for cancer patients.

BIDU - Slipped 2.50% despite beating earnings, due to an 18% year-over-year drop in online marketing revenue
TEM - Strong financial results with 83% YoY revenue growth to $1.27 billion, significant organic growth of 30%, and two major strategic partnerships with leading healthcare institutions that expand market reach and validate the company's cancer testing capabilities. Stock price increased 3.86% on the announcement.

#Tempus AI #cancer testing #genomic testing #revenue growth #strategic partnership #NYU Langone Health #Northwestern Medicine

Space Stocks Rip Into 2026 With Firefly In The Lead

Benzinga • Erica Kollmann

Space Stocks Rip Into 2026 With Firefly In The Lead

01/12/2026 02:44 PM • Space stocks surged into 2026 with multiple companies posting double-digit gains, driven by Trump administration support, technical achievements, and SpaceX IPO speculation. Firefly Aerospace leads with a 34% year-to-date gain, while AST SpaceMobile faces valuation concerns despite 28% gains. Rocket Lab, Planet Labs, and Intuitive Machines also show strong momentum, though Virgin Galactic lags with minimal gains.

TGT - Minimal gain of 0.034%, with expected earnings of $1.72 per share
ASTS - While up 28% year-to-date with strong retail interest, Scotiabank downgraded to Sector Underperform citing extreme valuation multiples, creating mixed signals between momentum and fundamental concerns.

#space stocks #2026 rally #Trump administration #SpaceX IPO #commercial space #lunar missions #defense contracts

GlobeNewswire Inc. • Na

ICIC Announces Board Chair Transition:

01/12/2026 02:40 PM • The Initiative for a Competitive Inner City (ICIC) announced a leadership transition with Ronald A. Homer stepping down as Board Chair after five years, to be succeeded by Jair K. Lynch, President and CEO of Jair Lynch Real Estate Partners. Lynch, who has served on ICIC's Board since 2017, brings over 30 years of experience in real estate development and urban regeneration with $3.4 billion in assets under management.

CUBE - CubeSmart is mentioned only as a board position held by Jair Lynch. The mention is factual and provides context about Lynch's leadership experience, with no direct business impact or news related to the company itself.

#leadership transition #board chair #real estate development #urban regeneration #inner city economic development #nonprofit organization

Nvidia Trades Cheap Relative to Its 2030s Earnings Path

Investing.com • Thomas Hughes

Nvidia Trades Cheap Relative to Its 2030s Earnings Path

01/12/2026 02:38 PM • Nvidia is trading at 40x current earnings but only 8x its 2035 earnings forecast, suggesting significant upside potential of 200-500% over the next decade. The company is expanding beyond GPUs into AI-enabled drug discovery (partnership with Eli Lilly), robotics, autonomous vehicles, and industrial applications. Analysts highlight robotics as a 2026 catalyst and expect Q4 2026 earnings to show 65%+ year-over-year revenue growth, with consensus rating of Buy and 40% upside potential.

NVDA - Stock is undervalued relative to 2030s earnings projections with 200-500% upside potential. Company is expanding into high-growth markets (drug discovery, robotics, autonomous vehicles). Strong analyst sentiment with Buy ratings and 40% upside consensus. Q4 2026 earnings expected to show 65%+ YoY revenue growth acceleration.

#Nvidia #AI #valuation #earnings forecast #drug discovery #robotics #Eli Lilly partnership #GPU #earnings growth

Greystone Capital Advisors Arranges $250 Million in Bridge Financing for 456-Unit Mixed Income Rental Development in Brooklyn, NY

GlobeNewswire Inc. • Greystone

Greystone Capital Advisors Arranges $250 Million in Bridge Financing for 456-Unit Mixed Income Rental Development in Brooklyn, NY

01/12/2026 02:31 PM • Greystone Capital Advisors arranged $250 million in bridge financing for AtlanticBK, a newly delivered 456-unit mixed-income residential development in Brooklyn. The refinancing replaced Wells Fargo's original $185 million construction loan, providing added flexibility and lower cost of capital to support lease-up and stabilization of the luxury rental community developed by Douglaston Development.

WFC - Originated both the original construction loan and the new bridge loan, maintaining the lending relationship. No negative or particularly positive developments indicated.

#bridge financing #multifamily residential #Brooklyn #lease-up #mixed-income housing #refinancing #commercial real estate finance

Beer Institute Releases November 2025 Taxable Removals Estimate Report

GlobeNewswire Inc. • Beer Institute

Beer Institute Releases November 2025 Taxable Removals Estimate Report

01/12/2026 02:00 PM • The Beer Institute reported November 2025 taxable removals of 10 million barrels, representing a 3.6% decrease compared to November 2024. Year-to-date removals through November 2025 show a 5.4% decline versus the same period in 2024, indicating a softening trend in beer production and sales across the American brewing industry.

TMUSZ - Mentioned as a parent company/advertising solutions provider with no specific action or performance highlighted
TAP - Molson Coors is mentioned only in the promotional content regarding an award to an employee. No specific performance data or company-related information is provided in the main article content.

#taxable removals #beer production #November 2025 #year-to-date decline #brewing industry #barrels

Marauder Capital Announces Expansion of Operating Partner Team

GlobeNewswire Inc. • Na

Marauder Capital Announces Expansion of Operating Partner Team

01/12/2026 02:00 PM • Marauder Capital, a Fort Worth-based private investment firm focused on energy and industrial services, announced the addition of Bryan Hoffman and Pedro Buhigas as Operating Partners. Hoffman brings decades of utility and infrastructure experience, while Buhigas contributes technology and operational expertise as CIO of Kodiak Gas Services. The appointments reflect the firm's commitment to operational excellence and long-term value creation.

TMUSL - Mentioned as a parent company/advertising solutions provider with no specific action or performance highlighted
KGS - Kodiak is mentioned only as the current employer of Pedro Buhigas, who will serve as an Operating Partner at Marauder Capital. The mention is informational without indicating any material impact on Kodiak's business or operations.

#operating partners #energy services #industrial services #private investment #operational efficiency #infrastructure #electrification

Ardent Health, Inc. (ARDT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Benzinga • Business Wire

Ardent Health, Inc. (ARDT) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

01/12/2026 01:46 PM • Law Offices of Howard G. Smith announced an investigation into Ardent Health, Inc. (NYSE: ARDT) for possible federal securities law violations. On November 12, 2025, Ardent reported a $43 million revenue decrease due to revised collectability of accounts receivable and a $54 million increase in professional liability reserves related to settlements and litigations from 2019-2022 in New Mexico. The stock fell 33.8% to $9.30 per share on November 13, 2025, prompting the law firm to solicit investors who suffered losses.

ARDT - The company disclosed significant financial issues including a $43 million revenue decrease, $54 million increase in liability reserves, and ongoing litigation. The stock experienced a sharp 33.8% decline following the announcement, and a securities fraud investigation has been initiated, indicating serious concerns about the company's financial reporting and management practices.

#securities fraud #investigation #revenue decrease #accounts receivable #professional liability #stock decline #shareholder losses

Industrial Names That Will Benefit from Rising CapEx in 2026

Investing.com • Chris Markoch

Industrial Names That Will Benefit from Rising CapEx in 2026

01/12/2026 01:45 PM • Industrial stocks are poised to extend their 2025 strength into 2026 due to sustained capital expenditure spending driven by infrastructure investments, energy transitions, and long-term government contracts. Three key companies highlighted are Emerson Electric (dividend growth story), Fluor Corp (energy and infrastructure focus), and Johnson Controls International (building modernization and AI cooling solutions).

EMR - Blue-chip industrial with sticky embedded revenue, 68-year dividend growth history, forecasted 8% EPS growth for 2026, and potential for analyst price target increases following February earnings report.

#industrial stocks #capital expenditure #infrastructure investment #energy transition #CapEx spending #dividend stocks #earnings growth

Critical Metals' 100% Run Puts Rare Earth Stocks In Play For 2026's Top Trade

Benzinga • Erica Kollmann

Critical Metals' 100% Run Puts Rare Earth Stocks In Play For 2026's Top Trade

01/12/2026 01:41 PM • Rare earth stocks are experiencing a significant bull run in early 2026, driven by geopolitical tensions and the Trump administration's focus on mineral sovereignty and reducing dependence on China. Critical Metals has surged 100% year-to-date, while other domestic rare earth producers and related ETFs have also rallied substantially. Key catalysts include Trump's interest in acquiring Greenland for its mineral resources and China's tightening of rare earth export restrictions, signaling the sector's critical importance to U.S. national security.

HPE - Viewed the platform as enabling faster, smarter, and more secure infrastructure
CRML - Stock has surged 100% since the beginning of 2026, described as the 'breakout star' in the sector, driven by investor interest in its Tanbreez project in Greenland and government focus on mineral sovereignty.

#rare earth metals #mineral sovereignty #geopolitical tension #China export restrictions #Greenland acquisition #national security #supply chain #critical minerals

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY)

Benzinga • Prnewswire

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Sun Country Airlines Holdings, Inc. (NASDAQ: SNCY)

01/12/2026 01:38 PM • Monteverde & Associates PC, a class action securities firm, has announced an investigation into Sun Country Airlines Holdings, Inc. regarding its proposed acquisition by Allegiant Travel Company. Under the deal terms, Sun Country shareholders would receive 0.1557 shares of Allegiant common stock and $4.10 in cash per share. The firm is investigating whether the transaction represents a fair deal for shareholders.

HPEpC - Viewed the platform as enabling faster, smarter, and more secure infrastructure
SNCY - The announcement of a class action investigation into the proposed acquisition suggests potential concerns about whether shareholders are receiving fair value in the transaction, which raises questions about deal fairness and may indicate undervaluation concerns.

#class action lawsuit #M&A investigation #acquisition #shareholder fairness #deal valuation

Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale

Benzinga • Vandana Singh

Alnylam Lays Out 2030 Vision, Bets On TTR Leadership And Pipeline Scale

01/12/2026 01:33 PM • Alnylam Pharmaceuticals announced its 'Alnylam 2030' five-year roadmap, targeting durable global leadership in transthyretin (TTR) diseases with plans to launch nucresiran by 2028-2030. The company projects 2026 net product revenue of $4.9-5.3 billion (71% growth), significantly above Street estimates, with TTR franchise expected to reach $4.4-4.7 billion. However, shares fell 10% on Monday despite strong guidance, as 2025 revenues narrowly missed expectations.

IBM - Looked forward to collaboration and highlighted potential for operational resiliency
ALNY - Positive strategic outlook with ambitious 2030 goals and strong 2026 revenue guidance significantly above Street estimates ($4.9-5.3B vs. lower expectations). However, negative price action (-10%) reflects disappointment that 2025 revenues narrowly missed estimates, suggesting market concerns about execution despite bullish forward guidance.

#Alnylam 2030 roadmap #TTR diseases leadership #nucresiran launch #revenue guidance 2026 #RNAi therapy #Amvuttra #Onpattro #blockbuster potential

This REIT Could Be One of the Best Companies to Own in 2026

The Motley Fool • Rick Munarriz

This REIT Could Be One of the Best Companies to Own in 2026

01/12/2026 01:33 PM • Realty Income (O), a REIT with a 5.5% dividend yield, is highlighted as a strong investment for 2026 due to its 666 consecutive monthly dividend payments and 133 straight quarters of dividend increases. The company owns approximately 15,500 properties leased primarily to recession-resistant businesses like supermarkets and convenience stores, maintaining a healthy 98.7% portfolio occupancy rate through its triple-net lease model.

LNVGY - Committed to infrastructure modernization and data protection
O - The article presents Realty Income as a class-act REIT with exceptional dividend stability, 133 consecutive quarters of dividend increases, a strong portfolio of recession-resistant properties (supermarkets and convenience stores), and a healthy 98.7% occupancy rate. The company is positioned as a safe, reliable income-generating investment suitable for 2026.

#REIT #dividend income #Realty Income #dividend aristocrat #real estate investment #recession-resistant #monthly dividends #portfolio occupancy

Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?

Benzinga • Piero Cingari

Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday?

01/12/2026 12:43 PM • Gold and silver surged to record highs Monday as investors reassessed Federal Reserve independence concerns following a DOJ criminal probe into Fed Chair Jerome Powell. The move sparked a rotation from Treasuries into precious metals. Financial stocks underperformed after Trump proposed capping credit card rates at 10%, while energy and tech stocks gained. Major indices showed modest gains ahead of inflation data and earnings season.

TMUSI - Mentioned as a parent company/advertising solutions provider with no specific action or performance highlighted
COF - Stock tumbled 6.6% following Trump's proposal to cap credit card interest rates at 10%, posting worst session since April 2025

#Federal Reserve independence #gold prices #silver prices #DOJ investigation #credit card interest rates #financial stocks #earnings season #inflation data

Aedifica NV/SA: Publication relating to a transparency notification

GlobeNewswire Inc. • Na

Aedifica NV/SA: Publication relating to a transparency notification

01/12/2026 12:00 PM • Aedifica, a Belgian public regulated real estate company listed on Euronext Brussels and Amsterdam, has published a transparency notification regarding a shareholding disclosure from BlackRock, Inc.

BLK - The notification merely reports BlackRock's shareholding in Aedifica as required by transparency regulations. This is a factual disclosure with no indication of strategic intent or market impact.

#transparency notification #shareholding disclosure #BlackRock #Aedifica #real estate company

Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

Benzinga • Vandana Singh

Pfizer Cancer Combo Drug Shows Strong Tumor Shrinkage in Colorectal Cancer Trial

01/12/2026 11:58 AM • Pfizer announced positive Phase 3 BREAKWATER trial data showing its Braftovi combination therapy (with cetuximab and FOLFIRI) demonstrated a 64.4% confirmed objective response rate in BRAF V600E-mutant metastatic colorectal cancer patients, significantly outperforming standard-of-care treatment (39.2%). The drug received accelerated FDA approval in December 2024, with continued approval contingent on verification of clinical benefit.

MDAIW - The company was featured prominently at a medical conference, received positive quotes from medical professionals, and was recognized on TIME's list of Top HealthTech companies, indicating strong technological and market potential
PFE - Pfizer's Braftovi combination therapy demonstrated clinically meaningful and statistically significant improvements in tumor response rates (64.4% vs 39.2%) compared to standard treatment, with 57.4% of patients achieving responses lasting 6+ months. This strong efficacy data supports the drug's accelerated FDA approval and validates the treatment approach for BRAF V600E-mutant colorectal cancer.

#Braftovi #encorafenib #colorectal cancer #BREAKWATER trial #BRAF V600E-mutant #objective response rate #FDA approval #cetuximab #metastatic colorectal cancer

Khaby Lame's TikTok Army Fuels Rich Sparkle's $4 Billion Sales Vision

Benzinga • Akanksha Bakshi

Khaby Lame's TikTok Army Fuels Rich Sparkle's $4 Billion Sales Vision

01/12/2026 11:57 AM • Rich Sparkle Holdings (NASDAQ: ANPA) completed its acquisition of Step Distinctive Limited, linked to TikTok star Khaby Lame, to leverage his 360 million followers for live-commerce sales. The company projects fan-driven sales could reach $4 billion annually through exclusive partnerships, AI-powered digital twins, and expansion across the US, Middle East, and Southeast Asia.

ANPA - The company completed a strategic acquisition to monetize a massive creator following (360M), projects significant revenue potential ($4B annually), and is implementing innovative AI digital twin technology for scalability. Stock trading above both 50-day and 200-day moving averages indicates strong technical momentum.

#acquisition #TikTok #live-commerce #digital twin #AI #creator economy #e-commerce #influencer marketing

Is Netflix a Buy Ahead of Earnings? It Looks Like It

Investing.com • Sam Quirke

Is Netflix a Buy Ahead of Earnings? It Looks Like It

01/12/2026 11:54 AM • Netflix stock has fallen 30% from all-time highs due to missed earnings, uncertainty around the Warner Bros. Discovery acquisition, and rising debt concerns. However, technical indicators suggest oversold conditions with RSI at 29 and a bullish MACD crossover. The stock trades at its lowest P/E ratio in years, and analysts from Morgan Stanley and Wolfe Research maintain Buy ratings with $120 price targets, suggesting significant upside from current $90 levels. The article argues much of the downside is already priced in ahead of the upcoming earnings report.

NFLX - Despite recent 30% decline from highs and October earnings miss, technical indicators show oversold conditions (RSI 29, bullish MACD crossover), valuation is at multi-year lows, and multiple analysts maintain Buy ratings with $120 price targets implying 33% upside from $90. Strong historical track record of beating expectations and much of negative sentiment already priced in ahead of earnings.

#Netflix earnings #stock valuation #technical analysis #oversold conditions #Warner Bros. Discovery acquisition #analyst ratings #buy opportunity